Home
Conditions
Stage IV Pancreatic Cancer

Clinical trial condition

Stage IV Pancreatic Cancer

Explore clinical trials studying Stage IV Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

70 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Stage IV Pancreatic Cancer trial results

Recruiting

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

NCT04150042

Conditions: Adenocarcinoma of the Breast, BRCA1 Mutation, BRCA2 Mutation, +35 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

NCT03095781

Conditions: Colonic Diseases, Colorectal Adenocarcinoma, Colorectal Neoplasms, +27 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Emory Saint Joseph's Hospital Atlanta, Georgia, United States

View Trial Details

Completed

Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

NCT02896907

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

NCT03154190

Conditions: Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +146 more
Locations: Virginia K Crosson Cancer Center Fullerton, California, United States

View Trial Details

Completed

APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery

NCT03087591

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +34 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

NCT01525082

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations: Stanford University Medical Center Stanford, California, United States

View Trial Details

Completed

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

NCT02178436

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Stony Brook University Cancer Center Stony Brook, New York, United States

View Trial Details

Completed

CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer

NCT01835041

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

NCT02333188

Conditions: Adenocarcinoma, Adenocarcinoma of Unknown Primary, Adult Cholangiocarcinoma, +35 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Decatur Memorial Hospital Decatur, Illinois, United States

NorthShore University Health System Evanston, Illinois, United States

Ingalls Memorial Hospital Harvey, Illinois, United States

View Trial Details

Completed

BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer

NCT02620865

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations: Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Stage IV Pancreatic Cancer

Stage IV Pancreatic Cancer trial results

Related conditions